CMS Proposes Non-Coverage For S&N Exogen For Nonunion Fracture Healing
This article was originally published in The Gray Sheet
Executive Summary
CMS is continuing its recent trend of promoting clinical trial coverage by proposing to extend reimbursement for Smith & Nephew's Exogen ultrasound bone growth stimulator for nonunion fracture healing for recipients enrolled in a qualifying trial